Unbundling for Managed Care
The recent move by Sulzer Group to spin off its SulzerMedica device business into a public company is the latest in a series of moves over the last few years in which companies have sought to increase shareholder value by creating separate businesses of more highly--in some cases, less highly--valued units.
You may also be interested in...
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.